Alignment plausibility: a proposal for evidence in mental-health AI
A preprint proposes assessing the values, training and continuous oversight of chatbots used for psychological support. It is an assurance framework, not certification or clinical evidence.
A chatbot can respond cautiously to a crisis prompt yet foster dependency over months of apparently kind conversation. A test of one reply would miss the second risk. On 8 July 2026, Gwydion Williams, Sara Zannone and Bilal A. Mateen published a preprint proposing a different object of assessment: whether a system’s stated values, training and deployment oversight form a credible chain towards safe outcomes. They call it alignment plausibility.
The name can sound like a technical seal, but it is not one. The arXiv record presents an author proposal, not an approved standard, clinical trial or product certification. Its value is to replace the vague question “is this model safe?” with a better one: what safety claim is being made, supported by which evidence, for what use, population and controls?
A chain with three links
The full preprint organises alignment plausibility into three levels. The first requires explicit values grounded in commitments from clinical practice: long-term wellbeing over immediate reassurance, autonomy over dependency, and honesty over collusive validation. Without that specification, training lacks a clear target and oversight lacks a standard against which to measure behaviour.
Stating values does not eliminate disagreement. Therapeutic friction may be appropriate in one setting and harmful in another. The authors acknowledge that a “clinical constitution” should not impose one doctrine: it would need different professional approaches, cultures and people with lived experience. That qualification matters. A values document makes choices contestable and auditable; it does not make them universal.
The second level is training. Pre-training data contain associations and stigma; post-training turns human or model preferences into reward signals. Several proxies sit between a value such as “protect autonomy” and a concrete reply: selected examples, annotations, automated judges and metrics. A system can optimise the proxy without satisfying the purpose. A written policy therefore demonstrates intent only; evidence must show whether learned behaviour preserves it under difficult conditions.
The third level is oversight during deployment. Pre-release tests and filters may detect an acute self-harm response, but dependency, boundary erosion or reinforcement of a distorted belief can accumulate across sessions. The preprint proposes monitoring conversational trajectories, defining escalation routes and revisiting the evidence when a harmful pattern appears. The analogy is clinical supervision: even a trained professional needs external review and continuing accountability.
What the framework does not demonstrate
The first limitation is the form of the paper. It is a 14-page conceptual argument, not a product comparison or patient study. Its illustration uses “TheraGPT”, a fictional product. The authors do not show that applying their three levels reduces harm, nor do they define a metric set or threshold beyond which a system can be declared safe.
The preprint itself says that measurement science, benchmarks and interpretability tools for alignment do not have depth comparable to the physiology and pharmacology supporting “biological plausibility”. It also leaves developers to choose suitable metrics, while allowing regulators to set minimum domains. That flexibility can fit evidence to a product, but it creates a risk: every provider may build a favourable argument with different, incomparable indicators.
The analogy with a clinician has another limit. A therapist works within competence requirements, duties, records, disciplinary mechanisms and a defined relationship. The British Association for Counselling and Psychotherapy’s ethical framework, for example, requires competence, boundaries, disclosure of risks, supervisory review and accountability for harm. Copying those principles into a model does not create a profession, legal duty or accountable person. The comparison can reveal missing components; it cannot establish equivalence.
Nor is every wellbeing conversation treatment. A general assistant, an app aimed at stress and a product claiming to diagnose or treat have different purposes and risks. An American Psychological Association presentation to the FDA’s digital-health committee separated those three classes: a regulated chatbot making medical claims, a direct-to-consumer mental-health service without those claims and a general assistant used as a companion. This was the APA’s position before an advisory committee, not an FDA decision, but it exposes a gap: actual use can become clinically sensitive even when a provider does not advertise treatment.
Turning three words into verifiable assurance
For the framework to work, every level needs artefacts an outsider can inspect. For values: the normative document, participants, resolved conflicts and behaviours deemed unacceptable. For training: data provenance and limits, evaluation examples, performance across groups and tests showing that the model can introduce appropriate friction without abandoning a user. For oversight: longitudinal indicators, review cadence, responsible parties, escalation routes and rules for pausing or changing the service.
A safety claim must also be bounded. “This LLM is safe for mental health” is too broad. An auditable form would specify product, version, function, population, duration and human intervention. The preprint stresses that plausibility belongs to the full system—model, fine-tuning, guardrails, interface and tools—under defined deployment controls. A base model does not automatically acquire or transfer the safety of one application.
The World Health Organization’s guidance on large models in health provides an external check: it calls for well-defined tasks, sufficient accuracy and reliability, participation by professionals and patients, post-release audits and impact assessments disaggregated by user type. Those requirements turn good intentions into observable questions. They also show why average accuracy alone cannot cover autonomy, privacy, equity or secondary effects.
The hard problem of monitoring relationships
Trajectory-level monitoring has a cost that the framework does not fully solve. Detecting dependency across sessions may require storing and analysing intimate conversations. The more context oversight collects, the greater the privacy risk may become. A serious system would need to justify what it retains, for how long, who can access it, how consent is obtained and whether trends can be evaluated without keeping identifiable text. Psychological safety and data minimisation can conflict.
A signal must also remain distinct from a diagnosis. Many conversations do not prove dependency; agreement does not establish a distorted belief; ending a session does not mean improvement. Longitudinal metrics require clinical validation and user participation to avoid labelling normal behaviour as danger. Monitoring should examine benefit as well as harm: a system that refuses every sensitive subject may record few incidents while being useless.
Oversight closes the loop only when it triggers decisions. If an indicator deteriorates, who investigates? Is the filter, fine-tuning or interface changed? Are affected users told? What threshold suspends a function? A dashboard without power to intervene is observation, not control. Every change should reopen the assurance case: evidence for one version cannot certify the next forever.
How to read a future claim of “clinical alignment”
A reader can test any product with six questions. Does it publish the concrete values it claims to follow? Does it show how they became data and tests? Does evaluation cover whole conversations as well as single replies? Are results separated by population and context? Is oversight independent and able to intervene? Does the claim apply to this exact version and purpose? Without those pieces, “aligned” states a commercial aspiration, not a guarantee.
The proposal from Williams, Zannone and Mateen does not yet solve every measurement problem. It does something prior and useful: it requires safety to be presented as a connected, revisable evidence case. That exposes weak links. A value may be unsuitable, training may fail to embed it, or monitoring may respond too late. Trust no longer rests on a polished demonstration but on a chain that can be challenged.
The transferable capability is to distinguish a plausibility case from an effectiveness case. The first explains why values, training and controls could produce a safe outcome; the second tests in real people and conditions whether they do. Mental-health systems need both. The preprint offers an architecture for demanding the first and acknowledges that many of its measurement tools still need to be built.
Sources for this piece
This piece draws on 3 primary source(s), gathered during reporting.
This article was produced with artificial intelligence under human editorial oversight.
